{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:59:45Z","timestamp":1764997185984,"version":"3.37.3"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T00:00:00Z","timestamp":1530144000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["200310004"],"award-info":[{"award-number":["200310004"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001961","name":"AXA Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001961","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12911-018-0619-5","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T05:07:10Z","timestamp":1530162430000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Development and evaluating multimarker models for guiding treatment decisions"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3945-853X","authenticated-orcid":false,"given":"Parvin","family":"Tajik","sequence":"first","affiliation":[]},{"given":"Mohammad Hadi","family":"Zafarmand","sequence":"additional","affiliation":[]},{"given":"Aeilko H.","family":"Zwinderman","sequence":"additional","affiliation":[]},{"given":"Ben W.","family":"Mol","sequence":"additional","affiliation":[]},{"given":"Patrick M.","family":"Bossuyt","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,6,28]]},"reference":[{"issue":"5","key":"619_CR1","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S1471-4914(01)01986-4","volume":"7","author":"BB Spear","year":"2001","unstructured":"Spear BB, Heath-Chiozzi M, Huff J. Clinical application of pharmacogenetics. Trends Mol Med. 2001;7(5):201\u20134.","journal-title":"Trends Mol Med"},{"key":"619_CR2","doi-asserted-by":"publisher","first-page":"e1553","DOI":"10.1136\/bmj.e1553","volume":"344","author":"X Sun","year":"2012","unstructured":"Sun X, Briel M, Busse JW, You JJ, Akl EA, Mejza F, Bala MM, Bassler D, Mertz D, Diaz-Granados N, et al. Credibility of claims of subgroup effects in randomised controlled trials: systematic review. BMJ. 2012;344:e1553.","journal-title":"BMJ"},{"key":"619_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1745-6215-11-85","volume":"11","author":"DM Kent","year":"2010","unstructured":"Kent DM, Rothwell PM, Ioannidis JP, Altman DG, Hayward RA. Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal. Trials. 2010;11:85.","journal-title":"Trials"},{"issue":"1 Suppl","key":"619_CR4","first-page":"85S","volume":"76","author":"WE Roberts","year":"1990","unstructured":"Roberts WE, Morrison JC, Hamer C, Wiser WL. The incidence of preterm labor and specific risk factors. Obstet Gynecol. 1990;76(1 Suppl):85S\u20139S.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"619_CR5","first-page":"168","volume":"75","author":"WN Spellacy","year":"1990","unstructured":"Spellacy WN, Handler A, Ferre CD. A case-control study of 1253 twin pregnancies from a 1982-1987 perinatal data base. Obstet Gynecol. 1990;75(2):168\u201371.","journal-title":"Obstet Gynecol"},{"issue":"9901","key":"619_CR6","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/S0140-6736(13)61408-7","volume":"382","author":"S Liem","year":"2013","unstructured":"Liem S, Schuit E, Hegeman M, Bais J, de Boer K, Bloemenkamp K, Brons J, Duvekot H, Bijvank BN, Franssen M, et al. Cervical pessaries for prevention of preterm birth in women with a multiple pregnancy (ProTWIN): a multicentre, open-label randomised controlled trial. Lancet. 2013;382(9901):1341\u20139.","journal-title":"Lancet"},{"issue":"1","key":"619_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/uog.15855","volume":"48","author":"P Tajik","year":"2016","unstructured":"Tajik P, Monfrance M, van 't Hooft J, Liem SM, Schuit E, Bloemenkamp KW, Duvekot JJ, Nij Bijvank B, Franssen MT, Oudijk MA, et al. A multivariable model to guide the decision for pessary placement to prevent preterm birth in women with a multiple pregnancy: a secondary analysis of the ProTWIN trial. Ultrasound Obstet Gynecol. 2016;48(1):48\u201355.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"619_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1515\/ijb-2012-0052","volume":"10","author":"H Janes","year":"2014","unstructured":"Janes H, Brown MD, Huang Y, Pepe MS. An approach to evaluating and comparing biomarkers for patient treatment selection. Int J Biostat. 2014;10(1):99\u2013121.","journal-title":"Int J Biostat"},{"key":"619_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-77244-8","volume-title":"Clinical prediction models: a practical approach to development, validation, and updating","author":"EW Steyerberg","year":"2009","unstructured":"Steyerberg EW. Clinical prediction models: a practical approach to development, validation, and updating. New York: Springer; 2009."},{"key":"619_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3462-1","volume-title":"Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis","author":"FE Harrell","year":"2001","unstructured":"Harrell FE. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York: Springer; 2001."},{"issue":"449","key":"619_CR11","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1080\/01621459.2012.695674","volume":"107","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Zeng D, Rush AJ, Kosorok MR. Estimating individualized treatment rules using outcome weighted learning. J Am Stat Assoc. 2012;107(449):1106\u201318.","journal-title":"J Am Stat Assoc"},{"issue":"4","key":"619_CR12","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1111\/j.1541-0420.2012.01763.x","volume":"68","author":"B Zhang","year":"2012","unstructured":"Zhang B, Tsiatis AA, Laber EB, Davidian M. A robust method for estimating optimal treatment regimes. Biometrics. 2012;68(4):1010\u20138.","journal-title":"Biometrics"},{"issue":"5","key":"619_CR13","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1177\/0962280211428383","volume":"22","author":"W Lu","year":"2011","unstructured":"Lu W, Zhang HH, Zeng D. Variable selection for optimal treatment decision. Stat Methods Med Res. 2011;22(5):493\u2013504.","journal-title":"Stat Methods Med Res"},{"issue":"3","key":"619_CR14","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/biom.12191","volume":"70","author":"C Kang","year":"2014","unstructured":"Kang C, Janes H, Huang Y. Combining biomarkers to optimize patient treatment recommendations. Biometrics. 2014;70(3):695\u2013707.","journal-title":"Biometrics"},{"issue":"6","key":"619_CR15","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1080\/10543406.2011.608052","volume":"21","author":"L Gunter","year":"2011","unstructured":"Gunter L, Zhu J, Murphy S. Variable selection for qualitative interactions in personalized medicine while controlling the family-wise error rate. J Biopharm Stat. 2011;21(6):1063\u201378.","journal-title":"J Biopharm Stat"},{"issue":"6","key":"619_CR16","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1162\/neco.2007.19.6.1633","volume":"19","author":"L Gunter","year":"2007","unstructured":"Gunter L, Zhu J. Efficient computation and model selection for the support vector regression. Neural Comput. 2007;19(6):1633\u201355.","journal-title":"Neural Comput"},{"issue":"24","key":"619_CR17","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1002\/sim.4322","volume":"30","author":"JC Foster","year":"2011","unstructured":"Foster JC, Taylor JM, Ruberg SJ. Subgroup identification from randomized clinical trial data. Stat Med. 2011;30(24):2867\u201380.","journal-title":"Stat Med"},{"issue":"2","key":"619_CR18","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1093\/biostatistics\/kxu049","volume":"16","author":"JC Foster","year":"2015","unstructured":"Foster JC, Taylor JM, Kaciroti N, Nan B. Simple subgroup approximations to optimal treatment regimes from randomized clinical trial data. Biostatistics. 2015;16(2):368\u201382.","journal-title":"Biostatistics"},{"issue":"2","key":"619_CR19","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/biostatistics\/kxq060","volume":"12","author":"T Cai","year":"2011","unstructured":"Cai T, Tian L, Wong PH, Wei LJ. Analysis of randomized comparative clinical trial data for personalized treatment selections. Biostatistics. 2011;12(2):270\u201382.","journal-title":"Biostatistics"},{"issue":"2","key":"619_CR20","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/j.1541-0420.2009.01282.x","volume":"66","author":"J Brinkley","year":"2010","unstructured":"Brinkley J, Tsiatis A, Anstrom KJ. A generalized estimator of the attributable benefit of an optimal treatment regime. Biometrics. 2010;66(2):512\u201322.","journal-title":"Biometrics"},{"issue":"2","key":"619_CR21","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/sim.5933","volume":"33","author":"E Dusseldorp","year":"2014","unstructured":"Dusseldorp E, Van Mechelen I. Qualitative interaction trees: a tool to identify qualitative treatment-subgroup interactions. Stat Med. 2014;33(2):219\u201337.","journal-title":"Stat Med"},{"issue":"1","key":"619_CR22","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1541-0420.2005.00420.x","volume":"62","author":"MS Pepe","year":"2006","unstructured":"Pepe MS, Cai T, Longton G. Combining predictors for classification using the area under the receiver operating characteristic curve. Biometrics. 2006;62(1):221\u20139.","journal-title":"Biometrics"},{"issue":"29","key":"619_CR23","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1093\/eurheartj\/ehu207","volume":"35","author":"EW Steyerberg","year":"2014","unstructured":"Steyerberg EW, Vergouwe Y. Towards better clinical prediction models: seven steps for development and an ABCD for validation. Eur Heart J. 2014;35(29):1925\u201331.","journal-title":"Eur Heart J"},{"issue":"2","key":"619_CR24","doi-asserted-by":"publisher","first-page":"e1001381","DOI":"10.1371\/journal.pmed.1001381","volume":"10","author":"EW Steyerberg","year":"2013","unstructured":"Steyerberg EW, Moons KG, van der Windt DA, Hayden JA, Perel P, Schroter S, Riley RD, Hemingway H, Altman DG, Group P. Prognosis research strategy (PROGRESS) 3: prognostic model research. PLoS Med. 2013;10(2):e1001381.","journal-title":"PLoS Med"},{"key":"619_CR25","doi-asserted-by":"publisher","first-page":"b375","DOI":"10.1136\/bmj.b375","volume":"338","author":"KG Moons","year":"2009","unstructured":"Moons KG, Royston P, Vergouwe Y, Grobbee DE, Altman DG. Prognosis and prognostic research: what, why, and how? BMJ. 2009;338:b375.","journal-title":"BMJ"},{"issue":"9","key":"619_CR26","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/heartjnl-2011-301246","volume":"98","author":"KG Moons","year":"2012","unstructured":"Moons KG, Kengne AP, Woodward M, Royston P, Vergouwe Y, Altman DG, Grobbee DE. Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker. Heart. 2012;98(9):683\u201390.","journal-title":"Heart"},{"issue":"9","key":"619_CR27","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/heartjnl-2011-301247","volume":"98","author":"KG Moons","year":"2012","unstructured":"Moons KG, Kengne AP, Grobbee DE, Royston P, Vergouwe Y, Altman DG, Woodward M. Risk prediction models: II. External validation, model updating, and impact assessment. Heart. 2012;98(9):691\u20138.","journal-title":"Heart"},{"key":"619_CR28","doi-asserted-by":"publisher","first-page":"b604","DOI":"10.1136\/bmj.b604","volume":"338","author":"P Royston","year":"2009","unstructured":"Royston P, Moons KG, Altman DG, Vergouwe Y. Prognosis and prognostic research: developing a prognostic model. BMJ. 2009;338:b604.","journal-title":"BMJ"},{"key":"619_CR29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","volume":"58","author":"R Tibshirani","year":"1996","unstructured":"Tibshirani R. Regresssion and shrinkage via the Lasso. J R Stat Soc Ser B. 1996;58:267\u201388.","journal-title":"J R Stat Soc Ser B"},{"issue":"3","key":"619_CR30","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1214\/13-AOS1096","volume":"41","author":"J Bien","year":"2013","unstructured":"Bien J, Taylor J, Tibshirani R. A Lasso for hierarchical interactions. Ann Stat. 2013;41(3):1111\u201341.","journal-title":"Ann Stat"},{"issue":"13","key":"619_CR31","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1093\/eurheartj\/ehu004","volume":"35","author":"J van der Leeuw","year":"2014","unstructured":"van der Leeuw J, Ridker PM, van der Graaf Y, Visseren FL. Personalized cardiovascular disease prevention by applying individualized prediction of treatment effects. Eur Heart J. 2014;35(13):837\u201343.","journal-title":"Eur Heart J"},{"issue":"4","key":"619_CR32","doi-asserted-by":"publisher","first-page":"253","DOI":"10.7326\/0003-4819-154-4-201102150-00006","volume":"154","author":"H Janes","year":"2011","unstructured":"Janes H, Pepe MS, Bossuyt PM, Barlow WE. Measuring the performance of markers for guiding treatment decisions. Ann Intern Med. 2011;154(4):253\u20139.","journal-title":"Ann Intern Med"},{"issue":"4","key":"619_CR33","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/j.0006-341X.2004.00242.x","volume":"60","author":"X Song","year":"2004","unstructured":"Song X, Pepe MS. Evaluating markers for selecting a patient\u2019s treatment. Biometrics. 2004;60(4):874\u201383.","journal-title":"Biometrics"},{"issue":"2","key":"619_CR34","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1214\/10-AOS864","volume":"39","author":"M Qian","year":"2011","unstructured":"Qian M, Murphy SA. Performance guarantees for individualized treatment rules. Ann Stat. 2011;39(2):1180\u2013210.","journal-title":"Ann Stat"},{"issue":"5","key":"619_CR35","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1056\/NEJMoa070641","volume":"357","author":"DJ Rouse","year":"2007","unstructured":"Rouse DJ, Caritis SN, Peaceman AM, Sciscione A, Thom EA, Spong CY, Varner M, Malone F, Iams JD, Mercer BM, et al. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med. 2007;357(5):454\u201361.","journal-title":"N Engl J Med"},{"issue":"6","key":"619_CR36","doi-asserted-by":"publisher","first-page":"763","DOI":"10.7863\/jum.2005.24.6.763","volume":"24","author":"AS Roman","year":"2005","unstructured":"Roman AS, Rebarber A, Pereira L, Sfakianaki AK, Mulholland J, Berghella V. The efficacy of sonographically indicated cerclage in multiple gestations. J Ultrasound Med. 2005;24(6):763\u20138. quiz 770-761","journal-title":"J Ultrasound Med"},{"issue":"9680","key":"619_CR37","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1016\/S0140-6736(09)60947-8","volume":"373","author":"JE Norman","year":"2009","unstructured":"Norman JE, Mackenzie F, Owen P, Mactier H, Hanretty K, Cooper S, Calder A, Mires G, Danielian P, Sturgiss S, et al. Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis. Lancet. 2009;373(9680):2034\u201340.","journal-title":"Lancet"},{"issue":"3","key":"619_CR38","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/AOG.0b013e31822ad6aa","volume":"118","author":"AC Lim","year":"2011","unstructured":"Lim AC, Schuit E, Bloemenkamp K, Bernardus RE, Duvekot JJ, Erwich JJ, van Eyck J, Groenwold RH, Hasaart TH, Hummel P, et al. 17alpha-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial. Obstet Gynecol. 2011;118(3):513\u201320.","journal-title":"Obstet Gynecol"},{"key":"619_CR39","first-page":"CD000110","volume":"2","author":"CA Crowther","year":"2000","unstructured":"Crowther CA. Hospitalisation and bed rest for multiple pregnancy. Cochrane Database Syst Rev. 2000;2:CD000110.","journal-title":"Cochrane Database Syst Rev"},{"issue":"13","key":"619_CR40","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1111\/j.1471-0528.2012.03504.x","volume":"119","author":"JM Schaaf","year":"2012","unstructured":"Schaaf JM, Hof MH, Mol BW, Abu-Hanna A, Ravelli AC. Recurrence risk of preterm birth in subsequent twin pregnancy after preterm singleton delivery. BJOG. 2012;119(13):1624\u20139.","journal-title":"BJOG"},{"issue":"3","key":"619_CR41","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/AOG.0b013e318184181a","volume":"112","author":"MS Esplin","year":"2008","unstructured":"Esplin MS, O'Brien E, Fraser A, Kerber RA, Clark E, Simonsen SE, Holmgren C, Mineau GP, Varner MW. Estimating recurrence of spontaneous preterm delivery. Obstet Gynecol. 2008;112(3):516\u201323.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"619_CR42","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/uog.3820","volume":"28","author":"L Sperling","year":"2006","unstructured":"Sperling L, Kiil C, Larsen LU, Qvist I, Schwartz M, Jorgensen C, Skajaa K, Bang J, Tabor A. Naturally conceived twins with monochorionic placentation have the highest risk of fetal loss. Ultrasound Obstet Gynecol. 2006;28(5):644\u201352.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"619_CR43","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1097\/00006250-200410000-00046","volume":"104","author":"American College of O, Gynecologists committee on practice B-O, Society for Maternal-Fetal M, committee AJE","year":"2004","unstructured":"American College of O, Gynecologists committee on practice B-O, Society for Maternal-Fetal M, committee AJE. ACOG practice bulletin #56: multiple gestation: complicated twin, triplet, and high-order multifetal pregnancy. Obstet Gynecol. 2004;104(4):869\u201383.","journal-title":"Obstet Gynecol"},{"key":"619_CR44","volume-title":"Harvard University Working Paper Series","author":"B Claggett","year":"2011","unstructured":"Claggett B, Zhao L, Tian L, Castagno D, Wei LJ. Estimating subject-specific treatment differences for risk-benefit assessment with operating risk event-time data. In: Harvard University Working Paper Series, vol. 125; 2011."},{"issue":"3","key":"619_CR45","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/biom.12192","volume":"70","author":"C Kang","year":"2014","unstructured":"Kang C, Janes H, Huang Y. Rejoinder: combining biomarkers to optimize patient treatment recommendations. Biometrics. 2014;70(3):719\u201320.","journal-title":"Biometrics"},{"key":"619_CR46","doi-asserted-by":"publisher","first-page":"d5888","DOI":"10.1136\/bmj.d5888","volume":"343","author":"JA Dorresteijn","year":"2011","unstructured":"Dorresteijn JA, Visseren FL, Ridker PM, Wassink AM, Paynter NP, Steyerberg EW, van der Graaf Y, Cook NR. Estimating treatment effects for individual patients based on the results of randomised clinical trials. BMJ. 2011;343:d5888.","journal-title":"BMJ"},{"key":"619_CR47","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1745-6215-8-14","volume":"8","author":"AJ Vickers","year":"2007","unstructured":"Vickers AJ, Kattan MW, Daniel S. Method for evaluating prediction models that apply the results of randomized trials to individual patients. Trials. 2007;8:14.","journal-title":"Trials"},{"key":"619_CR48","doi-asserted-by":"publisher","first-page":"i6","DOI":"10.1136\/bmj.i6","volume":"352","author":"AJ Vickers","year":"2016","unstructured":"Vickers AJ, Van Calster B, Steyerberg EW. Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests. BMJ. 2016;352:i6.","journal-title":"BMJ"},{"issue":"5","key":"619_CR49","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1373\/clinchem.2016.254268","volume":"62","author":"AJ Vickers","year":"2016","unstructured":"Vickers AJ. Incorporating clinical considerations into statistical analyses of markers: a quiet revolution in how we think about data. Clin Chem. 2016;62(5):671\u20132.","journal-title":"Clin Chem"},{"issue":"28","key":"619_CR50","doi-asserted-by":"publisher","first-page":"4906","DOI":"10.1002\/sim.5881","volume":"32","author":"SA Kovalchik","year":"2013","unstructured":"Kovalchik SA, Varadhan R, Weiss CO. Assessing heterogeneity of treatment effect in a clinical trial with the proportional interactions model. Stat Med. 2013;32(28):4906\u201323.","journal-title":"Stat Med"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-018-0619-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12911-018-0619-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-018-0619-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T19:52:17Z","timestamp":1720381937000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-018-0619-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,28]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["619"],"URL":"https:\/\/doi.org\/10.1186\/s12911-018-0619-5","relation":{},"ISSN":["1472-6947"],"issn-type":[{"type":"electronic","value":"1472-6947"}],"subject":[],"published":{"date-parts":[[2018,6,28]]},"assertion":[{"value":"17 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The data for this analysis were collected in the ProTwin trial (NTR1858), reported in detail elsewhere data.The ProTwin trial received ethics approval from the Medical Ethics Committee of the Academic Medical Centre of the University of Amsterdam, The Netherlands (MEC O9\/1O7), and received approval for local execution, in line with the Dutch legal requirements for research in humans, from all other participant center. All participants provided written informed consent prior to study entry and were aware that the data they contributed were used to analyze the effect of a pessary on pregnancy outcome in multiple pregnancies. The full names and affiliations of the AMC ethics committee are provided in the \u201cAMC Medical Ethics Committee Approval_ProTWIN\u201d letter which can be accessed at the trial website.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We declare that we have no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"52"}}